Ignota Labs, an AI-driven drug turnaround company, has closed a $6.9 million seed funding round, co-led by Montage Ventures ...

BridGene Biosciences Inc. has entered a strategic collaboration and licensing agreement with Takeda through which it will use ...

Sphere Fluidics has rebranded to Sphere Bio reflecting its transition from a droplet-based microfluidics innovator to a ...

Nimbus Therapeutics, LLC, a biotechnology company that designs and develops medicines leveraging its computational drug discovery engine, has achieved a significant preclinical milestone under its ...

IsomAb Ltd, a UK-based biotechnology company developing novel isoform-specific disease modifying antibody treatments, for peripheral arterial disease and other ischaemic conditions, has appointed Dr.

Solventum’s Purification & Filtration business is highly complementary to Thermo Fisher’s bioproduction business. Solventum’s ...

Geographic expansion and regulatory expertise: With an increasingly complex global regulatory environment, biopharma ...

Kineticos Life Sciences has launched Kinvard Bio Inc., a new anti-infectives biotech company based on research that has been ...

Ephicacy Consulting Group Inc., a biometrics Contract Research Organization (CRO), has appointed Tara Gladwell as Chief Executive Officer. In the meantime, founder Ganesh Gopal will transition to the ...

Swarm Oncology Ltd., a biotechnology company, has partnered with Cellex Cell Professionals GmbH, a contract development and ...

RedHill Biopharma Ltd., a specialty biopharmaceutical company, has entered into an exclusive worldwide development and commercialization licensing agreement, excluding North America, with Hyloris ...

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...